Metsera (MTSR) News Today $28.39 -1.06 (-3.60%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock MTSR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Metsera (NASDAQ:MTSR) Stock Price Up 10.3% - Here's WhyJuly 2, 2025 | marketbeat.comWall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - NasdaqJune 26, 2025 | nasdaq.comMetsera (NASDAQ:MTSR) Trading Down 6.3% - What's Next?June 23, 2025 | marketbeat.comWells Fargo Initiates Coverage of Metsera (MTSR) with Overweight RecommendationJune 20, 2025 | msn.comMetsera (NASDAQ:MTSR) Coverage Initiated by Analysts at Wells Fargo & CompanyJune 20, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Trading 6.4% Higher - Still a Buy?June 18, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Shares Gap Up - Time to Buy?June 16, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Shares Down 5.2% - Time to Sell?June 13, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Shares Up 4.5% - Time to Buy?June 12, 2025 | marketbeat.comPromising Results Of Amylin Analogs In Obesity: Metsera Case ReviewJune 12, 2025 | seekingalpha.comMetsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 ResultsJune 11, 2025 | msn.comCantor Fitzgerald Estimates Metsera FY2026 EarningsJune 11, 2025 | marketbeat.comMetsera extends gains after early-stage trial data for obesity therapyJune 10, 2025 | msn.comMetsera Clears Key Benchmark, Hitting 80-Plus RS RatingJune 10, 2025 | msn.comMetsera (NASDAQ:MTSR) Shares Gap Up After Analyst UpgradeJune 10, 2025 | marketbeat.comGuggenheim Issues Positive Forecast for Metsera (NASDAQ:MTSR) Stock PriceJune 10, 2025 | marketbeat.comMetsera to Present at Goldman Sachs 46th Annual Global Healthcare ConferenceJune 10, 2025 | globenewswire.comMetsera, Inc.: Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233iJune 9, 2025 | finanznachrichten.deMetsera shares soar on positive amylin candidate trial resultsJune 9, 2025 | investing.comObesity Newcomer Metsera, Up 23%, Enters The Ring With A PunchJune 9, 2025 | msn.comMetsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter ExplodesJune 9, 2025 | msn.comMetsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss DataJune 9, 2025 | benzinga.comMetsera (NASDAQ:MTSR) Hits New 12-Month High - What's Next?June 9, 2025 | marketbeat.comMetsera rises as experimental weight-loss drug shows promise in small early-stage trialJune 9, 2025 | reuters.comMetsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233iJune 9, 2025 | globenewswire.comMetsera (NASDAQ:MTSR) Trading Down 3.7% - Here's WhyJune 6, 2025 | marketbeat.comMetsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®June 5, 2025 | globenewswire.comMetsera (NASDAQ:MTSR) Shares Up 7.6% - Should You Buy?June 3, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Stock Price Down 6.9% - Should You Sell?May 31, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Trading 8.6% Higher - Here's What HappenedMay 29, 2025 | marketbeat.comCantor Fitzgerald maintains overweight on Metsera sharesMay 29, 2025 | uk.investing.comMetsera (NASDAQ:MTSR) Trading 13.4% Higher - Here's What HappenedMay 14, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Issues Quarterly Earnings ResultsMay 14, 2025 | marketbeat.comMetsera, Inc. Reports First Quarter 2025 Financial Results and Progress on Clinical Trials for Obesity TreatmentsMay 13, 2025 | nasdaq.comMetsera, Inc.: Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio ProgressMay 12, 2025 | finanznachrichten.deMetsera Reports First Quarter 2025 Financial Results and Continued Portfolio ProgressMay 12, 2025 | globenewswire.comMetsera Rings the Opening BellMay 9, 2025 | nasdaq.comMetsera Rings the Nasdaq Stock Market Opening BellMay 9, 2025 | nasdaq.comMetsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity PromiseMay 9, 2025 | seekingalpha.comMetsera to Present at Bank of America 2025 Global Healthcare ConferenceMay 8, 2025 | globenewswire.comMetsera (NASDAQ:MTSR) Stock Price Down 7.6% - What's Next?May 7, 2025 | marketbeat.comMetsera Inc. appoints new director and legal officerApril 30, 2025 | investing.comMetsera (NASDAQ:MTSR) Trading Up 5.7% - Here's What HappenedApril 30, 2025 | marketbeat.comMetsera, Inc. Appoints New Board Member and Legal OfficerApril 28, 2025 | tipranks.comMetsera (NASDAQ:MTSR) Shares Gap Up - Here's What HappenedApril 27, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Trading Up 4.7% - Still a Buy?April 23, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Stock Price Up 7.4% - Time to Buy?April 17, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Shares Down 12.6% - Here's What HappenedApril 11, 2025 | marketbeat.comMetsera (NASDAQ:MTSR) Hits New 52-Week Low - Here's What HappenedApril 10, 2025 | marketbeat.comBank of America Securities Remains a Buy on Metsera, Inc. (MTSR)April 9, 2025 | markets.businessinsider.com Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Email Address MTSR Media Mentions By Week MTSR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTSR News Sentiment▼0.590.57▲Average Medical News Sentiment MTSR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTSR Articles This Week▼14▲MTSR Articles Average Week Get Metsera News Delivered to You Automatically Sign up to receive the latest news and ratings for MTSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTRS News QGEN News MRNA News ASND News BBIO News BPMC News VRNA News ROIV News ELAN News RVMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MTSR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metsera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metsera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
